beraprost sodium and its Impurities
Beraprost is also being studied for use in avoiding reperfusion injury. It is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension.. Reference standards of Beraprost Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Sodium 4-((1R,2R,3aS,8bS)-2-hydroxy-1-((Z)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
Sodium 4-((1R,2R,3aS,8bS)-2-hydroxy-1-((Z)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
Catalogue No.:PA 02 26510
CAS :
NA
Molecular Formula : C24H29NaO5
Molecular Weight : 420.48
Methyl 4-(3-(3-((tert-butyldimethylsilyl)oxy)-5-oxocyclopent-1-en-1-yl)-2-((triethylsilyl)oxy)phenyl)butanoate
Methyl 4-(3-(3-((tert-butyldimethylsilyl)oxy)-5-oxocyclopent-1-en-1-yl)-2-((triethylsilyl)oxy)phenyl)butanoate
Catalogue No.:PA 02 0261001
CAS :
NA
Molecular Formula : C28H46O5Si2
Molecular Weight : 518.84
Methyl 4-((1R,2R,3aS,8bS)-2-hydroxy-1-((3S,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
Methyl 4-((1R,2R,3aS,8bS)-2-hydroxy-1-((3S,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
Catalogue No.:PA 02 0261002
CAS :
943544-75-0
Molecular Formula : C25H32O5
Molecular Weight : 412.53
